NovaBay Pharmaceuticals Dividend
Dividend criteriumcontroles 0/6
NovaBay Pharmaceuticals does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
-21.6%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | -21.6% |
| Toekomstig dividendrendement | n/a |
| Dividendgroei | n/a |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | n/a |
| Uitbetalingsratio | n/a |
Recente dividendupdates
Geen updates
Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if NBY's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if NBY's dividend payments have been increasing.
Dividendrendement versus markt
| NovaBay Pharmaceuticals Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (NBY) | n/a |
| Markt onderkant 25% (US) | 1.5% |
| Markt Top 25% (US) | 4.5% |
| Gemiddelde industrie (Pharmaceuticals) | 2.3% |
| Analist prognose (NBY) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Unable to evaluate NBY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate NBY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate NBY's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as NBY has not reported any payouts.